0
Lumos Diagnostics Holdings Limited Banner Image

Lumos Diagnostics Holdings Limited

  • Ticker LDX
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Lumos Diagnostics Holdings Limited Logo Image
  • 51-200 Employees
  • Based in Melbourne, Australia
Lumos Diagnostics Holdings Limited operates as an integrated developer and manufacturer of point-of-care (POC) diagnostic tests. The company develops and manufactures proprietary and in-licensed POC diagnostic tests. Its products include FebriDx, a test that differentiates between bacterial and viral respiratory infections; ViraDx, a combined COVID/Influenza test for acute respiratory infectionsMore; and CoviDx, an antigen test for COVID-19. The company also engages in the contract research and development services specialized in the innovation, development, commercialization, and manufacturing of point-of-care diagnostic solutions for clinical and consumer applications. It offers its products through distributors primarily in the North American and European markets. The company was founded in 2004 and is headquartered in Melbourne, Australia.
Lumos Diagnostics Holdings Limited

Most Recent Annual Report

Lumos Diagnostics Holdings Limited
MOST RECENT 2021 Annual Report